Best Life Sciences Tech Companies in Spain
The 68 best Life Sciences Tech companies in Spain in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Biorce.
- EVERSANA
- LifeSciencesIntelligence
Our analysis of 50 Life Sciences Tech companies
$9.6b in tracked funding; 89% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Tech companies in Spain
| # | Company | Last round | Disclosed funding | Stage | Employees | Founded | Founder | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | AFFINImeter Analysis software for molecular interactions | — | — | Funding Raised | — | 2013 | Juan Sabin Co-Founder & CEO | — | — |
| 2 | ALLOX AI-powered drug discovery platform to treat human diseases | — | — | Funding Raised | — | 2023 | Julia Domingo Co-Founder | — | 4 job openings |
| 3 | Aniling DNA sequencing solutions. | — | — | Funding Raised | 10 | 2014 | Lorenzo Coll CEO and Co-Founder | 5 patents High-throughput DNA sequencing and epigenetically modified DNA capture technologies | — |
| 4 | AntalGenics Developer of active molecules for biomedical and dermo-cosmetic applications | — | — | Funding Raised | 10 | 2015 | Asia Carvajal Founder | 19 patents Therapeutic TRPV1 modulators and phospholipase C‑inhibiting peptides for pain/inflammation treatment | — |
| 5 | ASM Soft LIMS,ERP & Operational management solutions | — | — | Unfunded | — | 1985 | Cesareo Barciela Carballido Owner | — | — |
| 6 | Bioinfile Bioinformatics solutions provider to optimize the species-level identification in microbiomes | — | — | Unfunded | — | 2023 | Pablo Yarza Founder & CEO | — | — |
| 7 | Biostatech Provider of bio-statistics solutions | — | — | Funding Raised | — | 2012 | Andrea Rebolledo Co-Founder | — | — |
| 8 | BIsiona Market Intelligence for pharma Industry. | — | — | Unfunded | — | 2005 | Ignacio Arroyo Cofounder | — | — |
Top 12 Life Sciences Tech companies in Spain
#1
Series A · Barcelona, Catalonia · founded 2024$61.5Mraised▾
Provider of a clinical assistant platform for drug development. It uses AI technology to de-risk and accelerate clinical trials, streamlining the process for pharmaceutical companies
- Feb 2026Series A$52M
- Jul 2025Seed$5.8M
- Nov 2024Seed$3.7M
#2
Series A · Barcelona, Catalonia · founded 2015 · 24 employees$9.5Mraised▾
Hardware and software solutions for computer-aided drug design. Products include PharmScreen- a ligand-based virtual screening tool that uses a 3D ligand-alignment algorithm based on the interaction fields for lead generation, and PharmQSAR- a 3D Quantitative Structure-Activity Relationship (QSAR) tool able to combine multiple fields of interaction.
- Feb 2026Series A$7.1M
- Aug 2022Grant (prize money)$50.1K
- Sep 2020Grant (prize money)$1.1M
- Apr 2020Grant (prize money)$1.1M
#3
Series A · Valencia, Valencian Community · founded 2015 · 90 employees$9.8Mraised▾
Developer of medical imaging software for radiomics and biomarker analysis. This software extracts quantitative features from medical images to support clinical research and diagnostic workflows. The platform manages, indexes, and harmonizes imaging data while integrating with electronic health records. It provides automated tools for analyzing specific organ systems, including the prostate, brain, liver, breast, and lung. These tools facilitate the calculation of volumetric data and the identification of imaging patterns to assist in disease classification and monitoring. The technology functions as a cloud-based system for processing and storing medical imaging data in compliance with data security standards.
- Jan 2025Series A$50.2M
- Oct 2020Grant (prize money)$99.8K
- Sep 2020Grant (prize money)$547K
- Jul 2020Seed$9.2M
#4
Seed · Oviedo, Asturias · founded 2021$770.9Kraised▾
Provider of artificial intelligence solutions with a focus on clinical microbiology and infectious diseases. The company offers IAST a tool to help in the antibiotic prescription process applying complex algorithms and iLynx AI-based product to analyze in real time, quantitative and qualitative information issued by doctors about drugs.
- Dec 2025Conventional Debt$211.8K
- Dec 2025Seed$559K
#5
Series A · Barcelona, Catalonia · founded 2013 · 23 employees$11.2Mraised▾
Sequentia Biotech offers services and technologies in the field of bioinformatics. Work is organised into four specialised divisions: Sequentia Green, Sequentia Health, Sequentia Research, and Sequentia Training. The offerings include bioinformatics services, NGS services along with software for data analysis. It also has custom databses such as database for Plant resistance gene database PRGdb, Variation DB etc.
- Sep 2024Series A$11.2M
- Sep 2022Grant (prize money)$2.1M
- 2021Grant (prize money)$61.3K
- Apr 2021Grant (prize money)$86.6K
#6
Series A · Esplugues De Llobregat, Catalonia · founded 2015$984.7Kraised▾
Provider of a platform for personal genomic analysis. The company provides DNA sequencing services and computing services for genomic analysis. Users can obtain, analyze and manage their complete genomic sequence from the company's cloud platform.
- Dec 2024Series A$5.3M
- Oct 2022Seed$984.7K
- Jun 2018Grant (prize money)$58.2K
- Jan 2018Grant (prize money)$60.1K
#7
Series A · Spain · founded 2016$13.1Mraised▾
Provider of an AI-based Software for collecting EMR for clinical research. The company leverages the power of unique medical records to provide valuable insights and solutions for the healthcare industry.
- Sep 2023Grant (prize money)—
- Sep 2023Series A$10.7M
- Sep 2020Seed$2.4M
- 2018Seed—
#8
Series A · Barcelona, Catalonia · founded 2018 · 39 employees$27.2Mraised▾
Provider of a bioinformatics platform for scientific data analysis and workflow management. The platform centralizes data, streamlines pipelines, and manages infrastructure within a secure environment. It integrates with existing on-premises systems and cloud platforms, maintaining control over data residency. The platform offers a unified environment for high-throughput, cost-effective computation, suitable for genomics and AI-based drug discovery. It facilitates collaboration between teams through an intuitive interface and secure APIs, ensuring reproducible workflows and auditability.
- Oct 2022Series A$21.7M
- Sep 2021Grant (prize money)—
- Sep 2021Seed$5.5M
#9
Seed · Barcelona, Catalonia · founded 2018 · 24 employees$2.3Mraised▾
Provider of a simulation based platform for doctors. It provides virtual clinical trials for cardiac resynchronization, cardiac cardiotoxicity, pain killer pumps, cardiac valve implants, flow rates, and concentrations for inhalers, drug delivery. It also provides a virtual cardiovascular system that incorporates the three fundamental physics electrical activity, mechanical deformation, and fluid mechanics. The respiratory system simulates definition fluid mechanics.
- 2023Grant (prize money)—
- Dec 2021Seed$2.3M
- Oct 2020Grant (prize money)$122.6K
#10
Funding Raised · Madrid, Community of Madrid · founded 2018 · 23 employees$1.9Mraised▾
Platform offering an AI powered solutions for biopharma research and diagnostics. It provides customized AI models that analyze clinical data to identify digital biomarkers, aiding in disease progression and treatment response assessment for personalized medicine. It also offers AI models to assist in screening and diagnosis, enhancing accessibility, and harmonization across different settings. The AI models address various health challenges, from blood cancers to neglected tropical diseases, aiming to enhance healthcare.
- Apr 2022Grant (prize money)$52.7K
- Nov 2019Grant (prize money)$1.8M
- Aug 2018Grant (prize money)—
- Jul 2018Grant (prize money)$58.4K
#11
Seed · Alcala de Henares, Community of Madrid · founded 2014 · 22 employees$1.3Mraised▾
AI-powered platform to automate content and optimize processes for businesses. It leverages machine learning algorithms to create new content based on a multiple inputs, including text, images, videos, and musical notes. It offers solutions for multiple industries, including life sciences, news automation, data collaboration, and advertising.
- May 2021Seed$1.3M
- Apr 2020Grant (prize money)$20K
- Aug 2017Seed—
- 2016Seed—
#12
Funding Raised · Barcelona, Catalonia · founded 2006 · 28 employees$1.6Mraised▾
Developing advanced tools and services for drug discovery applications. CT-link is Chemotargets’ state-of-the-art platform-independent software for large-scale off-target pharmacology and predictive safety of small molecule pharmaceuticals, cosmeceuticals, agrochemicals, and environmental pollutants. CT-link is a systems discovery package designed as a modular computational framework.
- Dec 2018Grant (prize money)$754.1K
- Jan 2018Grant (prize money)$812.9K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Tech coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Spain
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 1,045 Spain-affiliated papers.
- Universidad Internacional De La Rioja128
- Consejo Superior de Investigaciones Científicas40
- Universidad Complutense de Madrid29
- Universidade de Santiago de Compostela27
- University of Córdoba26
- Population1→5
- Flow cytometry1→5
- Mutant1→4
- DNA damage3→4
- Gene1→15
- Agriculture1→15
- Health benefits2→9
- Germplasm1→8
- In vivo2→8
- Agriculture2→15
- Context (archaeology)1→13
- Antibiotic resistance2→11
- Antimicrobial1→9
- Production (economics)1→9
Where biotechnology is researched across Spain
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.